1. Home
  2. EVEX vs SCTX Comparison

EVEX vs SCTX Comparison

Compare EVEX & SCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eve Holding Inc.

EVEX

Eve Holding Inc.

HOLD

Current Price

$1.60

Market Cap

582.0M

Sector

Industrials

ML Signal

HOLD

Logo Scribe Therapeutics Inc. Common Stock

SCTX

Scribe Therapeutics Inc. Common Stock

HOLD

Current Price

$17.00

Market Cap

536.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVEX
SCTX
Founded
2020
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
582.0M
536.5M
IPO Year
2020
2026

Fundamental Metrics

Financial Performance
Metric
EVEX
SCTX
Price
$1.60
$17.00
Analyst Decision
Buy
Strong Buy
Analyst Count
10
4
Target Price
$6.26
★ $57.00
AVG Volume (30 Days)
★ 1.1M
441.9K
Earning Date
11-05-2026
11-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.41
$13.50
52 Week High
$5.16
$39.60

Technical Indicators

Market Signals
Indicator
EVEX
SCTX
Relative Strength Index (RSI) 41.41 38.49
Support Level $1.41 $13.50
Resistance Level $2.81 $22.07
Average True Range (ATR) 0.12 2.23
MACD 0.02 -0.08
Stochastic Oscillator 73.02 23.90

Price Performance

Historical Comparison
EVEX
SCTX

About EVEX Eve Holding Inc.

Eve Holding Inc is a provider of Urban Air Mobility solutions. The company's operating segments are; eVTOL that includes; the design and production of electric vertical take-off and landing vehicles (eVTOLs) including fixed wing and helicopter operators, as well as lessors that purchase and manage aircraft on behalf of operators; Service and Operations Solutions segment which includes a portfolio of maintenance and support services focused on its and third-party eVTOLs; and the UATM segment, a new Urban Air Traffic Management system designed to allow eVTOLs to operate safely and efficiently in dense urban airspace alongside conventional aircraft and drones.

About SCTX Scribe Therapeutics Inc. Common Stock

Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.

Share on Social Networks: